Precision Antifungal Treatment Significantly Extends Voice Prosthesis Lifespan in Patients Following Total Laryngectomy.

Candida antifungal laryngectomy microbiology speech therapy voice prosthesis

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2020
Historique:
received: 17 12 2019
accepted: 22 04 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 9 6 2020
Statut: epublish

Résumé

Indwelling silicone valves called voice prostheses (VPs) are the gold standard for speech rehabilitation in patients with laryngeal cancer following total laryngectomy. Reported VP lifespans amongst these patients are highly variable but when devices fail patients experience loss of voice and an increase risk of chest infection. Early failure of VP is a current clinical concern that is associated with regular hospital visits, reduced quality of life and associated medical cost. Poly-microbial biofilms comprised of both bacterial and fungal microorganisms readily colonize VPs and are linked to loss of device performance and its early failure in addition to providing a reservoir for potential infection. Our detailed analysis of poly-microbial biofilm composition on 159 early failing VPs from 48 total laryngectomy patients confirmed

Identifiants

pubmed: 32508787
doi: 10.3389/fmicb.2020.00975
pmc: PMC7251058
doi:

Types de publication

Journal Article

Langues

eng

Pagination

975

Informations de copyright

Copyright © 2020 Pentland, Stevens, Williams, Baker, McCall, Makarovaite, Balfour, Mühlschlegel and Gourlay.

Références

Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1579-86
pubmed: 20432044
Laryngoscope. 2002 Apr;112(4):708-12
pubmed: 12152601
Scand J Dent Res. 1991 Oct;99(5):390-6
pubmed: 1754841
Br J Pharmacol. 2011 May;163(1):184-94
pubmed: 21323894
Antimicrob Agents Chemother. 2009 Sep;53(9):3914-22
pubmed: 19564370
J Appl Physiol (1985). 1998 Aug;85(2):642-52
pubmed: 9688743
Laryngorhinootologie. 2008 Mar;87(3):160-6
pubmed: 18098100
Diagn Microbiol Infect Dis. 2007 Dec;59(4):401-6
pubmed: 17888612
Curr Opin Microbiol. 2011 Aug;14(4):380-5
pubmed: 21741878
Head Neck. 2012 Jun;34(6):863-71
pubmed: 21953690
Adv Exp Med Biol. 2015;830:123-36
pubmed: 25366225
Clin Oral Investig. 2007 Sep;11(3):231-6
pubmed: 17333305
Appl Environ Microbiol. 1997 Oct;63(10):3810-7
pubmed: 9327543
FEMS Microbiol Lett. 1992 Jan 15;69(3):223-8
pubmed: 1555756
Infect Immun. 2002 Feb;70(2):878-88
pubmed: 11796623
J Bacteriol. 2001 Sep;183(18):5385-94
pubmed: 11514524
mBio. 2016 Oct 11;7(5):
pubmed: 27729510
J Med Microbiol. 2015 Mar;64(Pt 3):199-208
pubmed: 25106862
J Biomed Mater Res. 1997 Feb;34(2):201-9
pubmed: 9029300
J Biomed Mater Res B Appl Biomater. 2005 Apr;73(1):23-8
pubmed: 15660395
Clin Infect Dis. 2001 Oct 15;33(8):1387-92
pubmed: 11565080
Laryngoscope. 2010 Jun;120(6):1135-43
pubmed: 20513030
Arch Oral Biol. 1993 Dec;38(12):1057-63
pubmed: 8141667
Am J Infect Control. 2015 Jan;43(1):35-7
pubmed: 25564121
Oncotarget. 2016 Aug 30;7(35):56147-56152
pubmed: 27528229
Acta Otolaryngol. 2003 Oct;123(8):972-9
pubmed: 14606602
Microbiology. 2015 Jan;161(Pt 1):168-181
pubmed: 25332378
Otolaryngol Clin North Am. 2004 Jun;37(3):597-612
pubmed: 15163604
Nat Rev Genet. 2002 Dec;3(12):918-30
pubmed: 12459722
Ear Nose Throat J. 2012 Apr;91(4):E19-22
pubmed: 22522361
Infect Immun. 1983 Oct;42(1):285-92
pubmed: 6352497
Mycopathologia. 2001;151(1):5-10
pubmed: 11502064
Emerg Infect Dis. 2001 Mar-Apr;7(2):277-81
pubmed: 11294723
J Biomed Mater Res. 2001;58(5):556-63
pubmed: 11505431
Indian J Cancer. 2014 Apr-Jun;51(2):184-8
pubmed: 25104206
JAMA Otolaryngol Head Neck Surg. 2017 Jan 1;143(1):65-71
pubmed: 27684464
Clin Infect Dis. 2002 Nov 1;35(9):1066-70
pubmed: 12384840
Eur Arch Otorhinolaryngol. 1997;254(6):261-3
pubmed: 9248731
J Dent. 1998 Sep;26(7):577-83
pubmed: 9754746
Mol Oral Microbiol. 2014 Apr;29(2):90-8
pubmed: 24506943
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
Clin Microbiol Rev. 2002 Apr;15(2):167-93
pubmed: 11932229
Anal Chem. 2001 Feb 1;73(3):434-8
pubmed: 11217742
Infect Immun. 1982 Dec;38(3):921-4
pubmed: 7152678
J Appl Bacteriol. 1994 May;76(5):521-8
pubmed: 8005837
Laryngorhinootologie. 2001 Nov;80(11):677-81
pubmed: 11702284
Acta Otolaryngol. 1997 May;117(3):452-8
pubmed: 9199534
Eur Arch Otorhinolaryngol. 2014 Jan;271(1):133-40
pubmed: 23812585

Auteurs

Daniel R Pentland (DR)

Kent Fungal Group, School of Biosciences, University of Kent, Kent, United Kingdom.

Sarah Stevens (S)

East Kent Hospitals, University NHS Foundation Trust, Kent, United Kingdom.

Leila Williams (L)

East Kent Hospitals, University NHS Foundation Trust, Kent, United Kingdom.

Mark Baker (M)

East Kent Hospitals, University NHS Foundation Trust, Kent, United Kingdom.

Carolyn McCall (C)

East Kent Hospitals, University NHS Foundation Trust, Kent, United Kingdom.

Viktorija Makarovaite (V)

Kent Fungal Group, School of Biosciences, University of Kent, Kent, United Kingdom.

Alistair Balfour (A)

East Kent Hospitals, University NHS Foundation Trust, Kent, United Kingdom.

Friedrich A Mühlschlegel (FA)

Laboratoire National de Santé, Dudelange, Luxembourg.

Campbell W Gourlay (CW)

Kent Fungal Group, School of Biosciences, University of Kent, Kent, United Kingdom.

Classifications MeSH